Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologies
about
Pharmacodynamic profile of telithromycin against macrolide- and fluoroquinolone-resistant Streptococcus pneumoniae in a neutropenic mouse thigh modelPrevalence and molecular genetics of macrolide resistance among Streptococcus pneumoniae isolates collected in Finland in 2002.Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countriesSusceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 Pneumococci from 10 central and Eastern European countriesAntistreptococcal activity of telithromycin compared with seven other drugs in relation to macrolide resistance mechanisms in Russia.Emergence of a Streptococcus pneumoniae clinical isolate highly resistant to telithromycin and fluoroquinolones.Streptococcus pneumoniae isolates resistant to telithromycin.Antimicrobial susceptibility and macrolide resistance inducibility of Streptococcus pneumoniae carrying erm(A), erm(B), or mef(A).Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniaeActivities of telithromycin against 13,874 Streptococcus pneumoniae isolates collected between 1999 and 2003.Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumon
P2860
Q33555366-92F75649-ED84-4778-8C75-301EAD87E2C6Q34076998-0B74B135-6854-4700-A21C-038479156FD7Q34105515-95D5C061-8EF4-4259-A87A-E2282930A29BQ34105521-8E435BA2-B75A-4038-A8F1-FA3FC3E37EC9Q34112023-19FA406C-E08C-4062-8CC2-772037CBB379Q34143934-9B9AF7C0-A627-4DAC-83F0-125CC1806881Q34648611-32C2E8D7-6C36-41A6-88ED-73CF18EDB46DQ35166053-43DD3349-8090-41FE-A1F0-AC2853933893Q35547345-C2C83852-050C-4281-8CFD-C2974258C1EFQ37734496-3EB28187-1DB8-45F9-A62C-C6F38F017B47Q39478959-1547243F-9327-4C41-80DA-2D15C3BF0178
P2860
Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologies
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Antipneumococcal activity of t ...... d disk diffusion methodologies
@ast
Antipneumococcal activity of t ...... d disk diffusion methodologies
@en
type
label
Antipneumococcal activity of t ...... d disk diffusion methodologies
@ast
Antipneumococcal activity of t ...... d disk diffusion methodologies
@en
prefLabel
Antipneumococcal activity of t ...... d disk diffusion methodologies
@ast
Antipneumococcal activity of t ...... d disk diffusion methodologies
@en
P2093
P2860
P1476
Antipneumococcal activity of t ...... d disk diffusion methodologies
@en
P2093
M R Jacobs
P C Appelbaum
T A Davies
P2860
P304
P407
P577
2000-04-01T00:00:00Z